Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Hörselnedsättning, strategier och resultat på VA akutmottagningar (HearVA-ED)

30 september 2026 uppdaterad av: VA Office of Research and Development

Implementera HearVA (I-HearVA)

HearVA involves six VA facility emergency departments (ED) over a 3-year intervention period. The first part of this study will test whether providing personal amplifiers to Veteran ED patients who self-report hearing difficulty is acceptable to these patients, can improve their hearing, enhance understanding of discharge instructions, and can reduce the risk of coming back to the ED in a short period of time (3 days and 30 days). The second part of the study will then identify whether ED staff can implement this program and achieve similar results. The second part will give ED staff increasing levels of responsibility for screening Veterans for hearing difficulty and providing personal amplifiers when such difficulty is detected.

Studieöversikt

Detaljerad beskrivning

HearVA is a randomized controlled trial to explore the utility and outcomes of providing point-of-care access to hearing-impaired Veterans, comparing an offer of personal amplifiers versus control in an environment where the clinical stakes are high. It addresses a knowledge gap about the utility of providing such hearing assistance during clinical encounters. The study measures whether providing personal amplifiers is acceptable to older patients, can improve hearing, enhance understanding of discharge instructions, and improve care transitions at discharge. If such a strategy is beneficial, this simple low-tech approach has great potential for implementation and wide dissemination. HearVA-ED has two phases - the first, which has been completed, established the feasibility and acceptability of research and procedures in the ED environment through a pilot efficacy study and the second phase will be to complete a larger more definitive efficacy study and a detailed implementation study resulting in a strategic approach that can be widely disseminated across all VA emergency departments throughout the United States. This second phase will use a mixed-methods, hybrid effectiveness-implementation design to implement and evaluate the hearing assistance intervention in six VA Emergency Department Sites (in different facilities across the country). Implementation will occur in four stages with variation in the starting sequence at each site: The first group of two VA emergency departments will initiate implementation with an efficacy trial; second group of two sites will initiate implementation with delivery and support of personal amplifiers after screening and randomization by a research assistant (Stage 1); the third group of two sites will initiate implementation with the entire implementation (Stage 2) and the presence of a research assistant to conduct discharge interviews; and all sites will progress from this sequence to Stage 3 - Sustainability - which is the full implementation without research assistant presence.

Studietyp

Interventionell

Inskrivning (Beräknad)

1050

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studiekontakt

Studera Kontakt Backup

  • Namn: Lin T Tun
  • Telefonnummer: (646) 501-4132
  • E-post: lin.tun@va.gov

Studieorter

    • Colorado
      • Aurora, Colorado, Förenta staterna, 80045-7211
        • Rekrytering
        • Rocky Mountain Regional VA Medical Center, Aurora, CO
        • Kontakt:
    • New York
      • New York, New York, Förenta staterna, 10010-5011
        • Rekrytering
        • VA NY Harbor Healthcare System, New York, NY
        • Huvudutredare:
          • Joshua Chodosh, MD MSHS
        • Kontakt:
        • Kontakt:
      • Syracuse, New York, Förenta staterna, 13210-2716
        • Aktiv, inte rekryterande
        • Syracuse VA Medical Center, Syracuse, NY
      • The Bronx, New York, Förenta staterna, 10468
        • Rekrytering
        • James J. Peters VA Medical Center, Bronx, NY
        • Kontakt:
    • North Carolina
      • Durham, North Carolina, Förenta staterna, 27705-3875
        • Rekrytering
        • Durham VA Medical Center, Durham, NC
        • Kontakt:
    • Texas
      • Dallas, Texas, Förenta staterna, 75216-7167
        • Rekrytering
        • VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX
        • Kontakt:

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

60 år och äldre (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • English speaking
  • Emergency severity index criterion of 3 (medium), 4, or 5 (low acuity)
  • Hearing Handicap Inventory-Screen greater than or equal to 10 or positive answer to a single-item screening question
  • Capacity to consent to participate in research

Exclusion Criteria:

  • Inability to consent to participate in research
  • Emergency severity index criterion of 1-2 (high acuity)
  • Hearing Handicap Inventory-Screen less than 10 and negative answer to single item screening question
  • Inability to speak English
  • Using cochlear implants

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Behandling
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Intervention: Personal Amplifier

Consenting participants will be randomly assigned to the intervention group while receiving care in the emergency department

The intervention group will receive personal amplifiers (PockeTalkers) while they receive care in the ED

Andra namn:
  • Pocketalker
Övrig: Control: No Personal Amplifier

Consenting participants will be randomly assigned to the control group while receiving care in the emergency department

The control group will not receive personal amplifiers while they receive care in the ED

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Emergency department (ED) 3-day Readmissions
Tidsram: 3-5 days after initial ED stay

The Investigators will determine whether patients have had an ED revisit within three days through CPRS review as well as a brief follow-up phone call 3-5 days after ED discharge

3-5 days after initial ED stay

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Emergency department (ED) 30-day Readmissions
Tidsram: 30-35 days after initial ED stay

The Investigators will determine whether patients have had an ED revisit within 30 days through CPRS review as well as a brief follow-up phone call 30-35 days after ED discharge

30-35 days after initial ED stay
Patient-Rated Quality of Hearing, Understanding, and Communication With Providers During Emergency department (ED) Stay
Tidsram: Duration of ED stay, average of 1 day

Participants will self-rate their quality of hearing, understanding, and communication using a six item questionnaire. Scored on a 10-point Likert scale (1 = do not agree at all; 10 = completely agree) the questions will be: When I talked to the doctors and nurses today ... (1) their voices were very clear; (2) I was able to hear the sounds that I wanted to hear; (3) noises did not cause a problem for my hearing; and (4) listening did not make me tired. Two additional statements will explicitly capture understanding: (5) I was able to understand what they said; and (6) I was able to understand without making an effort. Higher scores will indicate better communication and understanding with providers.

Duration of ED stay, average of 1 day
Patient-Rated Quality of Post-Discharge Care
Tidsram: At time of discharge from ED, average 1 day

Patient-rated quality of post-discharge care using a three-item subset of the Care Transition Measure (CTM). The questions are scored on a 1-4 scale (1= strongly disagree; 4 = strongly agree): (1) The ED staff considered my preferences and those of my family or caregiver in deciding what my healthcare needs were for discharge; (2) Leaving the ED, I have a good understanding of the things I am responsible for in managing my health; (3) Leaving the ED, I clearly understand the purpose for each of my medications. Higher scores will indicate better discharge preparation.

At time of discharge from ED, average 1 day
Self-Reported Understanding of Discharge Instructions
Tidsram: 3-5 days after initial ED stay

Investigators will gauge self-reported understanding of discharge instructions using semi-structured interview data compared to documented discharge data.

3-5 days after initial ED stay

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Samarbetspartners

Utredare

  • Huvudutredare: Joshua Chodosh, MD MSHS, VA NY Harbor Healthcare System, New York, NY

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

8 december 2021

Primärt slutförande (Beräknad)

31 mars 2027

Avslutad studie (Beräknad)

31 mars 2027

Studieregistreringsdatum

Först inskickad

24 augusti 2021

Först inskickad som uppfyllde QC-kriterierna

30 augusti 2021

Första postat (Faktisk)

31 augusti 2021

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

5 oktober 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

30 september 2026

Senast verifierad

1 september 2026

Mer information

Termer relaterade till denna studie

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

produkt tillverkad i och exporterad från U.S.A.

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera